从知识到行动:通过MET exon 14跳过MET途径准MET途径的过程
Wiktoria Bogdanska1, Paul K Paik2,3
1Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Cancer
|April 2, 2025
概括
针对MET变化的向疗法,包括MET外显子14跳转,已经改变了非小细胞肺癌 (NSCLC) 治疗. 本综述涵盖了MET途径史,病理生理学以及NSCLC患者不断发展的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 1984年发现的MET通路在细胞生存和迁移中起着至关重要的作用.
- 在MET中发生的基因组变化,如MET外显子14 (METex14) 跳过,突变和放大,发生在3%-5%的非小细胞肺癌 (NSCLC) 患者中.
- 这些变化导致持续的MET受体激活,推动瘤的进展.
研究的目的:
- 审查MET途径的历史和病理生理学,重点关注NSCLC中METex14跳转.
- 检查MET改变NSCLC的诊断和治疗策略的演变.
- 讨论当前的治疗方法和克服抗药机制的未来方向.
主要方法:
- 对MET途径,METex14跳过和NSCLC的向疗法的文献综述.
- 对MET变化及其临床影响的历史和最近研究的分析.
- 检查与MET向剂相关的治疗结果和耐药性模式.
主要成果:
- 在一小部分NSCLC患者中,MET变化是显著的驱动因素.
- 下一代测序的发展使得这些变化的识别成为可能.
- 针对性疗法在具有特定MET变化的患者中已显示出有效性,从而改变了治疗环境.
结论:
- 在NSCLC中,METex14跳过和其他MET改变是可采取行动的目标.
- 了解MET途径的进步导致了新的治疗选择.
- 未来的研究应该专注于解决耐药性机制,以进一步改善患者的治疗结果.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
ER Retrieval Pathway
3.6K
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
3.6K
Translocation of Proteins into the Mitochondria
3.0K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.0K
Long-patch Base Excision Repair
6.9K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
6.9K
Mitochondrial Precursor Proteins
2.5K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.5K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K


